相关实验视频

Updated: May 13, 2026

Two Types of Assays for Detecting Frog Sperm Chemoattraction
10:02

Two Types of Assays for Detecting Frog Sperm Chemoattraction

Published on: December 27, 2011

19.2K

在子中封装的复合NGF对子精子特征和主要代谢途径的影响

Luigia Bosa1, Simona Mattioli1, Anna Maria Stabile2

  • 1Department of Agricultural, Food and Environmental Sciences, University of Perugia, 06121 Perugia, Italy.

Biology
|September 4, 2025
PubMed
概括

重组神经生长因子 (rrβNGFch) 增强精子电容和体反应,特别是在早期储存期间. 长期储存会对精子质量产生负面影响,ERK1/ 2信号与这些功能变化有关.

关键词:
体反应细胞亡容量设置子精子信号布

更多相关视频

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation08:24

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation

Published on: May 22, 2017

8.5K
Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

185

相关概念视频

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...